Money Concepts Capital Corp Anavex Life Sciences Corp. Transaction History

Money Concepts Capital Corp

  • $1.25 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023
SELL
$8.32 - $11.75 $5,391 - $7,614
-648 Reduced 4.77%
12,925 $110,000
Q4 2022

Feb 14, 2023
BUY
$7.65 - $14.43 $1,216 - $2,294
159 Added 1.19%
13,573 $125,000
Q3 2022

Oct 27, 2022
BUY
$8.9 - $12.86 $119,384 - $172,504
13,414 New
13,414 $138,000

Others Institutions Holding AVXL

# of Institutions
155
Shares Held
27.3M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $673M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email